Mangoceuticals (MGRX) Total Current Liabilities (2022 - 2026)

Mangoceuticals (MGRX) has 5 years of Total Current Liabilities data on file, last reported at $737606.0 in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 50.93% year-over-year to $737606.0; the trailing twelve-month figure through Mar 2026 stood at $737606.0 (down 50.93% YoY), and the FY2025 full-year result was $890568.0, down 37.52% from the prior year.
• Total Current Liabilities fell to $737606.0 in Q1 2026, from $890568.0 in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $159176.0 in Q3 2023.
• A 5-year average of $853861.2 and a median of $847421.5 in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 774.12% in 2024 and tumbled 50.93% in 2026, its largest moves.
• Tracing MGRX's Total Current Liabilities over 5 years: stood at $260577.0 in 2022, then declined by 19.0% to $211078.0 in 2023, then surged by 575.33% to $1.4 million in 2024, then plunged by 37.52% to $890568.0 in 2025, then fell by 17.18% to $737606.0 in 2026.
• Business Quant data shows MGRX's Total Current Liabilities at $737606.0 in Q1 2026, $890568.0 in Q4 2025, and $804275.0 in Q3 2025.